NCT02212587View on ClinicalTrials.gov

Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Patients Infected With Burkholderia Cepacia Complex

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Cystic FibrosisBurkholderia Cepacia Infection
Interventions
DRUG

TOBI

New inhalation devices such as the podhaler can administer tobramycin inhalation powder TIP/TOBI and achieve very high sputum drug levels. TOBI will be administered using the Podhaler

Trial Locations (2)

M5B 1W8

St. Michael's Hospital, Toronto

M5G 1X8

Hospital for Sick Children, Toronto

All Listed Sponsors
lead

Unity Health Toronto

OTHER

NCT02212587 - Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Patients Infected With Burkholderia Cepacia Complex | Biotech Hunter | Biotech Hunter